Review pivotal studies on Regenerative Therapies

As further applications of regenerative therapies are studied, due to advancements in biomedical science, the rapidly growing area of research in regenerative therapies may potentially provide benefits for a variety of diseases and health conditions. Below you will find just some of the thousands of pivotal studies on the effectiveness of regenerative therapies in orthopedics, immunomodulation, autoimmune diseases, diabetes, and many other indications that have been published in key medical journals, publications, and public studies, and that number is continuing to grow every day.

Tissue Repair

Regenerative cells' ability to differentiate and secrete trophic factors has important potential for tissue regeneration and repair.


Regenerative medicine was found to produce improvement in a large study of patients with rheumatoid arthritis according to validated questionnaires.


A study of Parkinson’s patients has demonstrated medium-term improvement with regenerative therapy.

Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson-s disease. Venkataramana NK et al. Translational Research. 2010 Feb. Abstract

Organ Transplant

Stem cells have been shown to improve organ acceptance in kidney transplant.

Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation. Perico N et al. Transplant International. 2013 Sep. Abstract


We partner with clinicians and institutions all over the world, introducing them to the potential of regenerative therapy and show them how they can harness the power of the latest regenerative technology to improve patient care and their quality of life.

Disclaimer: For Medical Professionals Only

This website is intended to inform and educate medical professionals. It is NOT intended for patients. It also does not seek to make claims about the effectiveness of regenerative medicine and its respective therapies in medical treatment.

Regenerative therapies have great potential in helping treat a range of conditions. This site serves to inform medical professionals about regenerative medicine, BioGenix allograft products, and key in vitro, animal model, and clinical research studies that have been carried out to date across medical specialties and health conditions. However, regenerative medicine is an early and evolving field, and clinical studies are still insufficient to determine effectiveness.

While the BioGenix products are produced in an FDA compliant laboratory, it has not been approved by the FDA for treatment effectiveness. The FDA states:

Like other medical products that are intended to treat, cure or prevent disease, generally require FDA approval before they can be marketed. FDA has not approved any stem cell-based products for use, other than cord blood-derived hematopoietic progenitor cells (blood-forming stem cells) for certain indications.

Patients interested in regenerative therapy in the U.S. are advised to consult a physician about the state of FDA approval for any given product and/or inquire about opportunities to participate in a clinical trial. Patients interested in regenerative therapies outside the U.S. should investigate regulations in the specific country. It is important to be aware that regulations and clinical study requirements vary from country to country.

By clicking yes you confirm that you are a medical professional, understand that the information contained in this website is intended for medical professionals and not for the general public, and have read and understood the disclaimer above.